Skip to main content
. 2002 Oct;40(10):3660–3665. doi: 10.1128/JCM.40.10.3660-3665.2002

TABLE 1.

Serotypes, place of isolation, antibiotic resistance patterns, PFGE types, and pbp2b/pbp2x/pspA restriction patterns of pneumococcal isolates

PFGE subtype(s) Serotype (no. of isolates)a Place of isolate recovery (yr[s]b) MIC range (μg/ml)
pbp2b/pbp2x/pspA restriction patterns Gen Bank accession no. of closest pspA CDRc sequence (% identity; clade) Antibiotype(s)d (in order of frequency)
Penicillin Ceftriaxone
1.1, 1.3, 1.5, 1.6 9V (5), France9V-3 Arezzo, Naples (97, 99, 00) 0.5-2 0.5-1 6/2/1, 6/2/2, 6/2/3 AF252286 (100:3) PG; PG, TX, EM, CC, TC
1.2 9A (1) Naples (00) 1 0.5 6/2/1 NDe PG, EM
1.4 14 (1) Bergamo (99) 2 0.5 6/2/1 ND PG
1.7 24F (1) Emilia-Romagna (98) 0.03 0.03 2/8/1 AF252286 (100; 3) No resistance
2.1 19A (3) Naples (98, 99) 0.12 0.03-0.12 10/27/4 AF253408 (100; 4) PG, EM, CC, TC; PG, EM, CC
2.1 15A (1) Palermo (98) 0.25 0.12 10/27/4 AF253408 (100; 4) PG, EM, CC, TC
3.1 24F (3) Naples (97, 98, 00) 0.5 0.06-0.25 27/8/8 AF253407 (100; 1) PG, EM, CC, TC
4.1, 4.2 6B (2) Parma, Bergamo (98, 99) 0.12 0.06 12/22/6 AF071805 (100; 1) PG, EM, CC, TC
12/22/7 AF254255 (99; 5)
5.1, 5.2 35F (2) Naples, Rome (99, 00) 0.12-0.25 0.06-0.25 5/4/11 AF071806 (98; 1) PG
6.1 6A (1) Rome (98) 0.5 ≤0.012 28/12/negative ND PG, EM, CC, TC
7.1 19F (1) Bologna (99) 0.5 0.25 29/28/5 AF252286 (100; 3) PG, EM, CC
8.1 23F (1) Naples (99) 2 1 30/9/9 AF288751 (100; 5) PG, TX, EM, CC, TC
9.1 19F (1) Naples (00) 0.5 0.12 negative/29/10 AF071812 (100; 2) PG, CH, EM, CC, TC
10.1-10.5 23F (7) Bergamo, Como, Monza, Pordenone (97, 98, 99, 00) ≤0.03 ≤0.12 2/8/12, 2/30/12, 2/8/17 AF253407 (100; 1) No resistance
AF253407 (100; 1)
11.1-11.6 14 (7), England14-9 Bergamo, Monza, Rome (98, 99) ≤0.03 ≤0.25 1/1/19 AF253406 (100; 1) EM, CC, TC; EM, CC; EM; TC
12.1, 12.2 3 (4) Bergamo, Milan, (87, 90, 98, 99) ≤0.03 ≤0.03 1/1/9, 2/8/9 AF288751 (100; 5) No resistance
13.1-13.3 12F (5) Naples, Milan, Florence (98) ≤0.03 ≤0.03 1/1/13 AF255552 (97; 2) No resistance
14.1 8 (2) Ferrara, Milan (98) ≤0.03 ≤0.03 2/1/29 AF253408 (93.5; 4) No resistance
15.1-15.3 4 (3) Bergamo, Naples, Feltre (91, 98, 00) ≤0.03 ≤0.03 2/8/31 ND No resistance
15.4 18C (1) Bergamo (00) ≤0.03 ≤0.03 2/1/31 ND No resistance
16.1, 16.2 7F (2) Bergamo (99) ≤0.03 ≤0.03 2/1/32 AF255545 (100; 2) No resistance
17.1, 17.2 9V (2) Bergamo (90, 99) ≤0.03 ≤0.03 1/1/20 ND No resistance
18.1 23A (1) Naples (98) ≤0.03 ≤0.03 2/8/25 ND No resistance
18.2 23F (1) Naples (98) ≤0.03 ≤0.03 1/8/25 ND EM, CC, TC
19.1 23F (1) Monza (98) ≤0.012 ≤0.012 1/1/14 ND No resistance
20.1 23F (1) Bergamo (99) ≤0.03 ≤0.012 1/8/15 ND No resistance
21.1 19A (1) Bergamo (99) ≤0.03 ≤0.012 1/1/24 ND No resistance
22.1 10A (1) Bergamo (96) ≤0.012 0.03 2/1/28 ND No resistance
23.1 9V (1) Bergamo (99) ≤0.03 0.03 2/1/23 ND TC
24.1 5 (1) Bergamo (96) ≤0.03 ≤0.012 1/1/21 ND No resistance
25.1 19F (1) Mantova (98) ≤0.012 ≤0.012 2/1/26 ND No resistance
26.1 1 (1) Merate (98) ≤0.012 ≤0.012 2/1/27 ND No resistance
27.1 1 (1) Rome (97) ≤0.012 ≤0.012 2/8/16 ND No resistance
28.1 33 (1) Bergamo (91) ≤0.03 ≤0.03 2/1/30 ND No resistance
29.1 22F (1) Naples (98) ≤0.012 ≤0.03 2/1/22 ND No resistance
30.1 1 (1) Bergamo (91) ≤0.012 ≤0.03 2/1/33 ND No resistance
31.1 10A (1) Bergamo (90) 0.03 ≤0.012 2/1/12 ND No resistance
32.1 4 (1) Naples (98) ≤0.012 0.03 2/8/34 ND No resistance
33.1 6B (1) Bergamo (99) 0.03 0.03 2/26/18 ND TC
a

Reference strains France9V-3 and England14-9 shared identical genetic profiles with PFGE subtype 1.1 and PFGE subtype 11.1 isolates, respectively.

b

Year designations are to be understood as preceded by “19” except for the designation 00, representing 2000.

c

CDR, clade-defining region.

d

PG, penicillin; TX, ceftriaxone; EM, erythromycin; CC, clindamycin; TC, tetracycline; CH, chloramphenicol.

e

ND, not determined.